INTEC PHARMA
Pharmaceutical distributor supplying medicines and medical devices to pharmacies and hospitals in Slovakia
Highlights
- ProfitableFY2025 net profit €129k · RÚZ
- New on EvolcAdded 2026-10-29
Recent signals
What changed at INTEC PHARMA in the last 6 months, newest first. Each line links to its public source.
- 15 May 2026 Public contract · Won €41k public contract from Stredoslovenský ústav srdcových a cievnych chorôb, a.s.: Rámcová dohoda crz.gov.sk
About INTEC PHARMA
INTEC PHARMA s.r.o. is a specialised pharmaceutical distribution company in Slovakia. It distributes prescription medicines, over-the-counter medicines, dietary supplements and medical devices, and runs an emergency ordering system for categorised medicines of one marketing authorisation holder, Octapharma.
Its customers are pharmacies, hospitals and other healthcare providers. Besides distribution, the company offers commercial and regulatory support to pharmaceutical manufacturers, including marketing and medical support, market access, pricing and reimbursement, regulatory and pharmacovigilance services, and the leasing of sales representatives.
The company was founded in 1990 and is headquartered in Bratislava, where its head office and distribution warehouse are located. A second distribution warehouse is in Prešov. The website states more than 30 years of experience in the market and lists an ISO 9001:2015 certificate.
Product: Wholesale distribution of prescription and OTC medicines, dietary supplements and medical devices, plus pharma commercial and regulatory services.
Financials
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | €20.6M | €17.9M | €8.2M | €5.2M | €11.6M |
| Growth | +15% | +120% | +57% | −55% | — |
| EBITDA | €229k | €175k | €103k | €108k | €16k |
| Operating profit | €189k | €145k | €85k | €78k | −€18k |
| Net profit | €129k | €61k | €47k | €54k | −€26k |
| Net margin | 0.6% | 0.3% | 0.6% | 1% | −0.2% |
| Personnel costs | €342k | €420k | €392k | €356k | €369k |
| Total assets | €6.1M | €6.4M | €5.3M | €3.3M | €5.5M |
| Cash | €21k | €21k | €286k | €138k | €86k |
| Liabilities | €4.9M | €5.3M | €4.3M | €2.4M | €4.2M |
| Equity | €1.1M | €1.0M | €956k | €909k | €1.1M |
As filed with RÚZ (Slovak register of financial statements). Each year links to its statement.
Public contracts
Contracts INTEC PHARMA signed since 1 Nov 2024, from the Slovak and Czech public contract registers. Values as published; amendments are not counted.
Customers
24 contracts with 14 buyers · €5.5M
| Contracts | Value | |
|---|---|---|
| Národný ústav srdcových a cievnych chorôb, a.s. Bratislava | 4 | €2.5M |
| Stredoslovenský ústav srdcových a cievnych chorôb, a.s. | 2 | €1.5M |
| Národný onkologický ústav | 4 | €969k |
| Fakultná nemocnica s poliklinikou F. D. Roosevelta Banská Bystrica | 1 | €117k |
| Univerzitná nemocnica Martin | 1 | €113k |
| Detská fakultná nemocnica Košice | 1 | €92k |
| Nemocnica s poliklinikou Brezno, n.o. | 1 | €43k |
| Fakultná nemocnica s poliklinikou Žilina | 2 | €36k |
Open public tenders for INTEC PHARMA →
Latest contracts
- 12 Oct 2026 for Všeobecná zdravotná poisťovňa a.s. · RÁMCOVÁ DOHODA č. 603/2026 register
- 12 Oct 2026 for Všeobecná zdravotná poisťovňa a.s. · RÁMCOVÁ DOHODA č. 602/2026 register
- 15 May 2026 for Stredoslovenský ústav srdcových a cievnych chorôb, a.s. · Rámcová dohoda · €41k register
- 27 Apr 2026 for Univerzitná nemocnica Martin · Kúpna zmluva č. 374/2026 · €113k register
- 12 Feb 2026 for Detská fakultná nemocnica Košice · Rámcová dohoda · €92k register
- 8 Jan 2026 for Národný ústav srdcových a cievnych chorôb, a.s. Bratislava · RD č. 196_2025 · €1.8M register
Public tenders won
18 tenders won since 1 Jan 2024 from 9 public buyers in Slovakia, worth €7.0M as awarded. From EU award notices (TED) that name INTEC PHARMA by its registry number.
- 16 Oct 2026 Všeobecná zdravotná poisťovňa, a.s. · Lieky ATC skupiny B02BD02 Koagulačný faktor VIII, parent rekomb (simoktokog alfa) notice
- 16 Oct 2026 Všeobecná zdravotná poisťovňa, a.s. · Lieky ATC skupiny B02BD04 Koagulačný faktor IX notice
- 11 Sep 2026 Univerzitná nemocnica Martin · Antitrombotické činidlá · €748k notice
- 8 May 2026 Univerzitná nemocnica Martin · Antianemické prípravky a antihemoragiká · €992k notice
- 15 Jan 2026 Národný ústav srdcových a cievnych chorôb, a.s. · KRVNÉ DERIVÁTY notice
- 13 Jan 2026 Národný ústav srdcových a cievnych chorôb, a.s. · KRVNÉ DERIVÁTY notice
Jobs at INTEC PHARMA
Leadership
- Gabriel Bodor · Konateľ (Managing director)Source: business register
- Ivana Polachová · Konateľ (Managing director)Source: business register
More biotech & pharma companies
JUHAPHARM
Pharmaceutical distribution, product development and industrial R&D for healthcare and industry clientsProfitableNew on EvolcKRKA Slovensko
Generic prescription, over-the-counter and veterinary medicines sold in Slovakia by the local unit of a foreign pharma groupProfitableMagnaPharm SK
Pharmaceutical import, local distribution and support services for manufacturers and customers in SlovakiaProfitableGrowingNew on EvolcMediXbank, n.o.
Nonprofit biomedical research and biobanking for researchers and healthcare professionalsNew on EvolcMGP
Distributes radiopharmaceuticals, contrast agents and radiation sources to healthcare, research and industry in Czechia and SlovakiaNew on EvolcMIKROCHEM
Pharmaceutical and chemical manufacturing and R&D services for pharmaceutical and chemical companies
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- WordPress
- nginx